Stinchcombe, T. E., Hodgson, L., Herndon, I. I. J. E., Kelley, M., Cicchetti, M. G., Ramnath, N., … Vokes, E. E. (2009). Identification of prognostic groups in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC) treated with chemoradiotherapy on Cancer and Leukemia and Group B trial (CALGB) 39801. JOURNAL OF THORACIC ONCOLOGY, 4(9), S522–S523.

Stinchcombe, Thomas E., Lydia Hodgson, II James E. Herndon, Michael Kelley, M Giulia Cicchetti, Nithya Ramnath, Harvey Niell, et al. “Identification of prognostic groups in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC) treated with chemoradiotherapy on Cancer and Leukemia and Group B trial (CALGB) 39801.” JOURNAL OF THORACIC ONCOLOGY 4, no. 9 (September 1, 2009): S522–23.

Stinchcombe TE, Hodgson L, Herndon IIJE, Kelley M, Cicchetti MG, Ramnath N, et al. Identification of prognostic groups in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC) treated with chemoradiotherapy on Cancer and Leukemia and Group B trial (CALGB) 39801. JOURNAL OF THORACIC ONCOLOGY. 2009 Sep 1;4(9):S522–3.

Stinchcombe, Thomas E., et al. “Identification of prognostic groups in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC) treated with chemoradiotherapy on Cancer and Leukemia and Group B trial (CALGB) 39801.” JOURNAL OF THORACIC ONCOLOGY, vol. 4, no. 9, LIPPINCOTT WILLIAMS & WILKINS, Sept. 2009, pp. S522–23.

Stinchcombe TE, Hodgson L, Herndon IIJE, Kelley M, Cicchetti MG, Ramnath N, Niell H, Atkins JN, Akerley W, Green MR, Vokes EE. Identification of prognostic groups in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC) treated with chemoradiotherapy on Cancer and Leukemia and Group B trial (CALGB) 39801. JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2009 Sep 1;4(9):S522–S523.